News Posts List
Common Household Product Ingredient Linked to Cancer
12/01/2011
Scientists from Nanyang Technological University (NTU) have found a possible link between a popular ingredient in cosmetics and cancer.
Cancer-Fighting Cells Get Boost From Viagra
11/29/2011
Viagra may provide more than a wake-up to a man's sex life – it may help the body's immune system fight cancer, a new study involving mice suggests.
Patient-friendly summaries: 10th International Symposium
11/29/2011
An excellent, easy-to-understand, summary of the 10th International Kidney Cancer Symposium, as reported by Joyce Wilcox Graff, Director of Wellness, VHL Family Alliance.
IDMC Recommends Analysis of RENCAREX Trial
11/22/2011
Over the last year the recurrence rate has further declined leading the advisers to conclude that the trial has matured such that the final analysis can be conducted now instead of after 512 events as originally planned.
New! Kidney Cancer Drug Info Sheets
11/20/2011
The following Drug Information Sheets (PDFs) will help you to learn more about these, including common side effects that users may experience.
Connecticut Medicaid Recipients Need Your Help
11/19/2011
...during its November meeting. CT MedicaidÂ’s P&T decision requiring doctors to go through a prior authorization process for some agents, but not others, creates a two tiered system that is not grounded in the evidence that oncologists utilize to make their treatment decisions.
Cancer Research UK launches nine high-tech gene projects
11/19/2011
The Genomics Initiative will use the latest high-tech gene sequencing machines to address specific research questions that until now were impossible to answer.
FDA Revokes Avastin Approval
11/18/2011
Medicare says it will continue to cover Avastin for breast cancer treatment, even if the FDA withdraws it for such use.
Molecules Capture Rare Tumor Cells In Blood
11/18/2011
The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers...
FDA Considers New Treatment for Advanced RCC
11/16/2011
...the committee will discuss new drug application (NDA) 202324, with the proposed trade name INLYTA (axitinib) tablets, application submitted by Pfizer Inc. The proposed indication (use) for this product is for the treatment of patients with advanced renal cell carcinoma (RCC, kidney cancer).
News Feed